Cancer Therapy Current Events | Cancer Therapy News | 10
|
| Page
10 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
McGill researchers overcome chemotherapy resistance in the lab
Researchers from McGill University's Faculty of Medicine have discovered a compound that reduces resistance to chemotherapy agents used to treat cancer. Their results were published in the June issue of The Journal of Clinical Investigation (JCI). view more (2008-06-30)
New targeted therapy shows promise in children with metastatic gastrointenstinal stromal tumor
Children with a rare digestive-tract cancer that is resistant to front-line therapy have benefited from a newer targeted therapy that has been shown effective in adults. view more (2006-06-05)
Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase... view more... (2009-10-29)
Cancer risk slightly higher for women in discontinued hormone treatment trial
A follow up study of participants in the Women's Health Initiative (WHI) clinical trial led by a University of North Carolina at Chapel Hill researcher has found that women who were taking the combined hormone therapy of estrogen plus progestin may have an increased risk of cancer since the intervention was stopped, compared to participants in the... view more... (2008-03-05)
Standard treatment for lung cancer should be changed, say scientists
Embargoed: 09.00 hrs CET Tuesday 23 September 2003 Copenhagen, Denmark: Patients with non-small cell lung cancer (NSCLC) are more likely to survive if they have chemotherapy after surgery than if they have surgery alone, said a scientist at ECCO 12 The European Cancer Conference in Copenhagen today (Tuesday 23 September). Dr. Bengt Bergman, of the... view more... (2003-09-21)
Herceptin plus chemotherapy significantly increases disease-free survival in breast cancer
Combining the molecularly targeted therapy Herceptin with chemotherapy in women with early stage breast cancer significantly improves disease-free survival for patients with a specific genetic mutation that results in very aggressive disease. view more (2006-12-18)
Colon cancer a disease of hormone deficiency, Jefferson team finds
Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have found new evidence suggesting that colon cancer is actually a disease of missing hormones that could potentially be treated by hormone replacement therapy. view more (2007-08-01)
Cryoablation is a safe procedure for breast cancer patients, early results indicate
Ultrasound-guided cryoablation of small breast cancer may be a safe procedure associated with minimal morbidity and high patient satisfaction. view more (2007-05-07)
Prostate cancer therapy may increase risk of death from heart disease in older men
Androgen deprivation therapy-one of the most common treatments for prostate cancer-may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women's Hospital and other institutions. view more (2007-02-26)
Swiss study suggests surgery may offer best chance of long-term prostate cancer survival
A study from Switzerland suggests that men who have surgery for prostate cancer appear less likely to die of the disease within 10 years than men who choose other treatment options, especially if they are younger or have cancers with certain tumor cell characteristics. view more (2007-10-09)
Chemotherapy given directly to the liver improves survival for patients with colorectal cancer
A new study shows that patients whose colorectal cancer has spread to the liver who received an approach called hepatic arterial infusion (HAI)- the administration of chemotherapy directly to the liver through a pump in the abdomen-fare better than those who received traditional, intravenous chemotherapy. view more (2006-02-28)
New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenib
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. view more (2008-07-24)
Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. view more (2008-10-31)
Study identifies potential 'safe period' for hormone replacement use
A new study makes important new findings on the role of hormone use on the risk of breast cancer, confirming that the use of estrogen plus progesterone increases the risk of both ductal and lobular breast cancer far more than estrogen-only; suggesting a two-year "safe" period for the use of estrogen and progesterone; and finding that the... view more... (2009-02-02)
Cost-benefit analysis: Combo treatment costs more, saves money later
From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective. view more (2006-11-08)
Fox Chase researchers identify differences in treatments and outcomes of patients with second primary lung cancers versus those with one primary lung cancer
Patients with second primary lung cancers (SPLC), when compared to those with one primary lung cancer (OPLC), are more likely to have localized disease at the time of diagnosis and are more likely to receive surgical treatment rather than radiation treatment. view more (2009-08-03)
Childhood cancer survivors at increased risk of sarcoma
Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma—a cancer of connective or supportive tissue such as bone, fat, or muscle—compared with the general population. view more (2007-02-21)
Toward a nanomedicine for brain cancer
In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells. view more (2009-09-10)
Automatic slicing system: Ex-vivo culture normal and cancerous pancreatic tissue
Pancreatic cancer is a devastating disease with a very poor prognosis. This warrants the development of novel therapies including gene therapy. Several of these treatments were found to be effective in pre-clinical (animal) models. However, in the subsequent clinical studies in patients the results were disappointing. view more (2009-03-24)
Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center. view more (2008-01-15)
|
|
| Page
10 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
|
